Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Adherium Ltd. ( (AU:ADR) ) has shared an announcement.
Adherium Ltd. has announced the quotation of 71,005,701 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective November 14, 2025. This move is part of the company’s strategy to enhance its capital structure, potentially strengthening its market position in the digital health sector and providing additional resources to support its growth and innovation initiatives.
More about Adherium Ltd.
Adherium Ltd. operates in the healthcare industry, focusing on developing and providing digital health technologies, particularly for respiratory conditions. The company is known for its innovative solutions that integrate with inhalers to monitor medication adherence, aiming to improve patient outcomes and reduce healthcare costs.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.69M
Learn more about ADR stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “Losing the Console Race by Miles”: Microsoft Stock (NASDAQ:MSFT) Ticks Up as the Console Wars Gain a Bit of Clarity
- “…In 18 Months This is a $35,000 Truck” Tesla Stock (NASDAQ:TSLA) Surges With New Pricing Projections
- “Historic Union Busting”: Starbucks Stock (NASDAQ:SBUX) Slips as Strikes Gain Ground, Draw Congress Reps